These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10070275)

  • 21. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
    Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
    Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing production of matrix metalloproteinases, tumor necrosis factor-α, vascular endothelial growth factor and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts by different adiponectin isoforms in a concentration-dependent manner.
    Li BT; Zhang FZ; Xu TS; Ding R; Li P
    Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):27-32. PubMed ID: 26567601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
    Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
    Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells.
    Yasui T; Akatsuka M; Tobetto K; Hayaishi M; Ando T
    Agents Actions; 1992 Sep; 37(1-2):155-6. PubMed ID: 1456177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor.
    Shibata-Nozaki T; Ito H; Mitomi H; Akaogi J; Komagata T; Kanaji T; Maruyama T; Mori T; Nomoto S; Ozaki S; Yamada H
    Arthritis Rheum; 2011 Sep; 63(9):2595-605. PubMed ID: 21898865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs.
    Seitz M; Loetscher P; Dewald B; Towbin H; Baggiolini M
    J Rheumatol; 1997 Aug; 24(8):1471-6. PubMed ID: 9263137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
    Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory PGE2 production is maintained during hypoxia in rheumatoid synovial fibroblasts.
    McGough KA; Jackson JR; Minton JA; Marshall LA; Jacobs RS; Winkler JD
    Inflamm Res; 1997 Aug; 46 Suppl 2():S147-8. PubMed ID: 9297554
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
    Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
    J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of synovial cell proliferation and prostaglandin E2 production by combined action of cytokines.
    Jorgensen C; Angel J; Fournier C
    Eur Cytokine Netw; 1991; 2(3):207-15. PubMed ID: 1893073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The differential responses of human skin and synovial fibroblasts to stanozolol in vitro: production of prostaglandin E2 and matrix metalloproteinases.
    Ellis AJ; Wright JK; Cawston TE; Hazleman BL
    Agents Actions; 1992 Mar; 35(3-4):232-7. PubMed ID: 1529798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo.
    Woods JM; Tokuhira M; Berry JC; Katschke KJ; Kurata H; Damergis JA; Arai K; Koch AE
    J Investig Med; 1999 Jul; 47(6):285-92. PubMed ID: 10431483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
    Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone.
    Ozawa T; Koyama K; Ando T; Ohnuma Y; Hatsushika K; Ohba T; Sugiyama H; Hamada Y; Ogawa H; Okumura K; Nakao A
    Mod Rheumatol; 2007; 17(6):459-63. PubMed ID: 18084696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.
    Pérez-García S; Juarranz Y; Carrión M; Gutiérrez-Cañas I; Margioris A; Pablos JL; Tsatsanis C; Gomariz RP
    J Cell Physiol; 2011 Dec; 226(12):3261-9. PubMed ID: 21360527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs.
    Yoon HY; Lee EG; Lee H; Cho IJ; Choi YJ; Sung MS; Yoo HG; Yoo WH
    Int J Mol Med; 2013 Oct; 32(4):971-7. PubMed ID: 23934131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.
    Gui H; Liu X; Wang ZW; He DY; Su DF; Dai SM
    Rheumatology (Oxford); 2014 May; 53(5):802-9. PubMed ID: 24440992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.